Apollo Medical Holdings Inc
NASDAQ:ASTH
Apollo Medical Holdings Inc
NASDAQ:ASTH
Price:
25.05
USD
2.2%
Market Closed
Market Cap:
$1.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Apollo Medical Holdings Inc
NASDAQ:ASTH
|
US |
|
Brunello Cucinelli SpA
MIL:BC
|
IT |
|
Chunghwa Telecom Co Ltd
TWSE:2412
|
TW |
|
Bright Health Group Inc
NYSE:NEUE
|
US |
|
T
|
Tinexta SpA
MIL:TNXT
|
IT |
|
India Power Corporation Ltd
NSE:DPSCLTD
|
IN |
|
GSE Systems Inc
NASDAQ:GVP
|
US |
|
D
|
Daido Group Ltd
HKEX:544
|
HK |
|
W
|
Williamson Magor and Co Ltd
NSE:WILLAMAGOR
|
IN |
|
M
|
Mesb Bhd
KLSE:MESB
|
MY |
|
ProCredit Holding AG & Co KGaA
XETRA:PCZ
|
DE |
|
Clearsign Technologies Corp
NASDAQ:CLIR
|
US |
|
K
|
Kwung's Holdings Ltd
HKEX:1925
|
CN |
|
P
|
Phoenix Asia Holdings Ltd
NASDAQ:PHOE
|
HK |
Multiples-Based Value
The
Multiples-Based Value for
Apollo Medical Holdings Inc (ASTH)
under the Base Case is
hidden
USD.
Compared with the current market price of 25.05 USD, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ASTH Multiples-Based Value
LOCKED
Multiples Across Competitors
ASTH Competitors Multiples
Apollo Medical Holdings Inc Competitors
Apollo Medical Holdings Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Apollo Medical Holdings Inc
NASDAQ:ASTH
|
1.2B USD | 0.4 | 54.5 | 12.4 | 18.2 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
93.4B USD | 0.2 | 52.8 | 13.7 | 13.7 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
67.2B EUR | 0.3 | 13.1 | 7.7 | 9.8 | |
| US |
|
Cigna Corp
NYSE:CI
|
71.1B USD | 0.3 | 11.9 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
24.5B EUR | 1.1 | 19.4 | 9.2 | 13.8 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.5B EUR | 1.1 | 23 | 8.9 | 16.5 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.5B USD | 1.6 | 25.6 | 12.3 | 17.8 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.8B USD | 2 | 22 | 11.9 | 16.1 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 0.6 | 11 | 5.3 | 9.8 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
12.3B USD | 12.5 | -29.4 | -32.2 | -29.2 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10B USD | 0.7 | 13.4 | 7 | 9.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
